Board meeting scheduled for April 30, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
Board to consider recommending dividend for FY 2025-26, subject to shareholder approval at AGM.
Trading window closed from March 31, 2026 to May 2, 2026 inclusive due to insider trading regulations.